InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Schiller Mark C.. Director active across 1 company, notably Kezar Life Sciences, Inc.. Cumulatively, 1 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €4k. Activity tracked since 2 July 2024. The latest transaction was disclosed on 2 July 2024 (Cession). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration